Effect of engineered mesoporous silica particles with tailored pore size on glycaemic control in individuals with prediabetes or type 2 diabetes: a randomised, double-blind, placebo-controlled SHINE trial

Jeanha Baek, Anna Ioannidou, Melissa L. Borg, Ghislaine Robert-Nicoud, Kirsi H. Pietiläinen, Stephan Rössner, Eric V. Johnston, Tore Bengtsson

Open source

DOI
10.1016/j.eclinm.2026.104042
Published
2026-07
Container
eClinicalMedicine
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.eclinm.2026.104042,
  title = {Effect of engineered mesoporous silica particles with tailored pore size on glycaemic control in individuals with prediabetes or type 2 diabetes: a randomised, double-blind, placebo-controlled SHINE trial},
  author = {Jeanha Baek and Anna Ioannidou and Melissa L. Borg and Ghislaine Robert-Nicoud and Kirsi H. Pietiläinen and Stephan Rössner and Eric V. Johnston and Tore Bengtsson},
  year = {2026},
  journal = {eClinicalMedicine},
  doi = {10.1016/j.eclinm.2026.104042},
  url = {https://doi.org/10.1016/j.eclinm.2026.104042}
}

RIS

TY  - JOUR
TI  - Effect of engineered mesoporous silica particles with tailored pore size on glycaemic control in individuals with prediabetes or type 2 diabetes: a randomised, double-blind, placebo-controlled SHINE trial
AU  - Jeanha Baek
AU  - Anna Ioannidou
AU  - Melissa L. Borg
AU  - Ghislaine Robert-Nicoud
AU  - Kirsi H. Pietiläinen
AU  - Stephan Rössner
AU  - Eric V. Johnston
AU  - Tore Bengtsson
PY  - 2026
JO  - eClinicalMedicine
DO  - 10.1016/j.eclinm.2026.104042
UR  - https://doi.org/10.1016/j.eclinm.2026.104042
ER  - 

APA

Baek, J., Ioannidou, A., Borg, M. L., Robert-Nicoud, G., Pietiläinen, K. H., Rössner, S., Johnston, E. V., & Bengtsson, T. (2026). Effect of engineered mesoporous silica particles with tailored pore size on glycaemic control in individuals with prediabetes or type 2 diabetes: a randomised, double-blind, placebo-controlled SHINE trial. eClinicalMedicine. https://doi.org/10.1016/j.eclinm.2026.104042

Source records